FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
Recruiting
This clinical trial is designed to test whether a single stereotactic intracerebral administration of inhibitory nerve cells into subjects with drug-resistant mesial temporal lobe epilepsy is safe (frequency of adverse events) and effective (seizure frequency).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/08/2023
Locations: Medical College of Wisconsin, Milwaukee, Wisconsin
Conditions: Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
Analysis of Electrocorticographic Signals
Recruiting
The objectives of this research are to understand how the brain can keep information in mind ("working memory"), and use this information to guide behavior. The two experiments that fall under this study will collect brain signals from epilepsy patients who are having surgery as part of their treatment. More specifically, these signals will be studied from the time while the patient is performing two cognitive tasks.The endpoints are publication of the results from each of the proposed experimen... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/19/2023
Locations: University of Wisconsin, Madison, Wisconsin
Conditions: Epilepsy